 
The Patent Office Journal 31/08/2012 
13668
(12) PATENT APPLICATION PUBLICATION (21) Application No.596/MUMNP/2012 A 
(19) INDIA  
(22) Date of filing of Application :12/03/2012 (43) Publication Date : 31/08/2012 
  
(54) Title of the invention : HBV ANTISENSE INHIBITORS  
  
(51) International classification  :A61K 31/7115  
(31) Priority Document No  :61/252,380  
(32) Priority Date  :16/10/2009 
(33) Name of priority country  :U.S.A. 
(86) International Application No 
        Filing Date 
:PCT/US2010/052911
:15/10/2010 
(87) International Publication No  :WO/2011/047312  
(61) Patent of Addition to Application 
Number  
        Filing Date 
:NA 
:NA 
(62) Divisional to Application Number 
        Filing Date 
:NA 
:NA  
  
(71)Name of Applicant :  
   1)GLAXO GROUP LIMITED 
      Address of Applicant :GLAXO WELLCOME HOUSE, 
BERKELEY AVENUE, GREEENFORD MIDDLESEX UB6 
0NN UNITED KINGDOM. 
(72)Name of Inventor : 
   1)HAMATAKE , ROBERT  
(57) Abstract : 
Antisense oligomers useful for modulating hepatitis B virus infections, and for the treatment of hepatitis B virus (HBV) and hepatitis 
B virus-related conditions in animals including humans. More particularly, antisense oligomers with modified nucleotides for 
treatment of HBV in animals, more particularly antisense oligomers comprising 2O-4C- methylene-bridged sugars, or nucleotides 
with other 2O-4C bridged sugars, also known as locked nucleic acids (LNA), for treatment of HBV in animals, and more particularly 
for treatment of HBV in humans. 
  
  
No. of Pages : 57 No. of Claims : 37 
